Indianapolis, INDIANA4 Active Studies

Type 1 Diabetes Clinical Trials in Indianapolis, INDIANA

Find 4 actively recruiting type 1 diabetes clinical trials in Indianapolis, INDIANA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,206
Enrolling

Recruiting Type 1 Diabetes Studies in Indianapolis

About Type 1 Diabetes Clinical Trials in Indianapolis

Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. It typically develops in childhood or young adulthood and requires lifelong insulin therapy. Research is exploring artificial pancreas systems, immunotherapy, and beta cell replacement.

There are currently 4 type 1 diabetes clinical trials recruiting participants in Indianapolis, INDIANA. These studies are seeking a combined 1,206 participants. Research is being sponsored by Eli Lilly and Company, Zucara Therapeutics Inc., Emily K. Sims and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Type 1 Diabetes Clinical Trials in Indianapolis — FAQ

Are there type 1 diabetes clinical trials in Indianapolis?

Yes, there are 4 type 1 diabetes clinical trials currently recruiting in Indianapolis, INDIANA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What type 1 diabetes treatments are being tested?

The 4 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for type 1 diabetes.

Data updated March 2, 2026 from ClinicalTrials.gov